111 related articles for article (PubMed ID: 27664390)
1. Transient Factor V deficiency associated with Factor V-immunoglobulin complexes but without evidence of a classical inhibitor.
Cortier D; Van Dreden P; Adam M; Bironien R; François D; Vasse M
Thromb Res; 2016 Nov; 147():10-12. PubMed ID: 27664390
[No Abstract] [Full Text] [Related]
2. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.
Ajzner E; Balogh I; Haramura G; Boda Z; Kalmár K; Pfliegler G; Dahlbäck B; Muszbek L
J Thromb Haemost; 2003 May; 1(5):943-9. PubMed ID: 12871359
[TBL] [Abstract][Full Text] [Related]
3. An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1.
Jeimy SB; Krakow EF; Fuller N; Tasneem S; Hayward CP
J Thromb Haemost; 2008 Feb; 6(2):395-7. PubMed ID: 18047547
[No Abstract] [Full Text] [Related]
4. Quantitation of coagulant antigens and inhibition of activated protein C in combined factor V VIII deficiency.
Giddings JC; Sugrue A; Bloom AL
Br J Haematol; 1982 Nov; 52(3):495-502. PubMed ID: 6812616
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.
Sridharan M; Fylling KA; Ashrani AA; Chen D; Marshall AL; Hook CC; Cardel LK; Nichols WL; Pruthi RK
Thromb Res; 2018 Nov; 171():14-21. PubMed ID: 30227314
[TBL] [Abstract][Full Text] [Related]
6. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy.
Takahashi H; Fuse I; Abe T; Yoshino N; Aizawa Y
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):87-93. PubMed ID: 12544735
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy of an acquired factor V inhibitor.
Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
[TBL] [Abstract][Full Text] [Related]
8. Acquired factor V deficiency in a patient without evidence of a classical inhibitor.
Sosa IR; Ellery P; Mast A; Neff AT; Gailani D
Haemophilia; 2014 Jan; 20(1):e81-3. PubMed ID: 24118596
[No Abstract] [Full Text] [Related]
9. Immunological studies in combined factor V and factor VIII deficiency.
Giddings JC; Seligsohn U; Bloom AL
Br J Haematol; 1977 Oct; 37(2):257-64. PubMed ID: 603759
[TBL] [Abstract][Full Text] [Related]
10. The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency.
Breederveld K; Giddings JC; ten Cate JW; Bloom AL
Br J Haematol; 1975 Mar; 29(3):405-12. PubMed ID: 1103945
[TBL] [Abstract][Full Text] [Related]
11. Factor V inhibitor in neonatal intracranial hemorrhage secondary to severe congenital factor V deficiency.
Lee WS; Chong LA; Begum S; Abdullah WA; Koh MT; Lim EJ
J Pediatr Hematol Oncol; 2001 May; 23(4):244-6. PubMed ID: 11846304
[TBL] [Abstract][Full Text] [Related]
12. The potential value of thrombin generation assay in the diagnosis of FV inhibitors.
Désage S; Jousselme E; Le Quellec S; Lienhart A; Nougier C; Dargaud Y; Jourdy Y
Int J Lab Hematol; 2019 Oct; 41(5):e117-e120. PubMed ID: 30953579
[No Abstract] [Full Text] [Related]
13. Development of cephradine-induced acquired factor V inhibitors: a case report.
Wu MT; Pei SN
Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866
[TBL] [Abstract][Full Text] [Related]
14. A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
Fujita Y; Nakazato T; Ito C; Masuda K; Osada Y; Aisa Y; Mori T
Ann Hematol; 2018 Oct; 97(10):2009-2010. PubMed ID: 29713749
[No Abstract] [Full Text] [Related]
15. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
16. [Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations].
Alcantara M; Ducastelle S; Rugeri L; Dargaud Y
Rev Med Interne; 2011 May; 32(5):e59-61. PubMed ID: 20638758
[TBL] [Abstract][Full Text] [Related]
17. A case of hereditary spherocytosis associated with factor V deficiency.
Morishita K; Fujii H; Asano S; Fujimaki M; Miwa S
Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):208-11. PubMed ID: 6858567
[No Abstract] [Full Text] [Related]
18. Severe factor V deficiency and neonatal intracranial haemorrhage: a case report.
Salooja N; Martin P; Khair K; Liesner R; Hann I
Haemophilia; 2000 Jan; 6(1):44-6. PubMed ID: 10632741
[TBL] [Abstract][Full Text] [Related]
19. [Deficiency of factor V in obstetrics and gynecology].
Almuna R; Testa E; Muranda M; Suarez L
Rev Chil Obstet Ginecol; 1976; 41(6):429-34. PubMed ID: 1032844
[No Abstract] [Full Text] [Related]
20. Factor V inhibitor associated with immune complex formation.
Lazarchick J; Wolff CM; Pepkowitz SH; Kizer J; Romein LA
Arch Pathol Lab Med; 1986 May; 110(5):448-51. PubMed ID: 3754431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
